Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Eli Lilly Stock Still a Top-Growth Play?

TheMotleyFool

0 0

Is Eli Lilly Stock Still a Top-Growth Play?

Eli Lilly (NYSE: LLY) has been on an epic run of late. Thanks to the excitement over its Alzheimer's disease and weight-loss assets, Lilly's shares have clobbered the broader markets over the past three years. There is a downside associated with Lilly's meteoric rise, however. The company's stock is now trading at over 52 times projected earnings, making it the most expensive big pharma stock right now.